AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.100
+0.035 (3.29%)
At close: Dec 5, 2025, 4:00 PM EST
1.080
-0.020 (-1.82%)
After-hours: Dec 5, 2025, 7:29 PM EST
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $30.14 million as of December 5, 2025. Its market cap has increased by 0.88% in one year.
Market Cap
30.14M
Enterprise Value
-31.78M
1-Year Change
0.88%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $30.14M, a decrease of -89.28%. That is a compound annual growth rate of -45.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 29.18M | -29.22% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |